西班牙Certest腺病毒六鄰體重組蛋白
廣州健侖生物科技有限公司
廣州健侖長期供應各種生物原料，主要代理品牌：西班牙Certest。
Certest Biotec，S.L. 是一家獨立的生物技術公司，致力于人類臨床領域的IVD診斷產品的開發和制造?？焖贆z測是基于快速、準確和易于操作的診斷產品。 此外，Cerstest還有多種實時PCR產品，可以用于醫院臨床、實驗室科研等。
Certest公司于2002年在薩拉戈薩成立，是一家創新技術型公司。公司的發展是基于新產品的開發、市場空間和機遇的探索，十幾年來一直以高度專業化，以客戶為導向，不斷得創新，優化產品，專業知識，取得廣大客戶的信任和支持。Certest的質量體系已通過ISO 13485認證。
主要產品包括各種生物單克隆抗原抗體、重組蛋白。
輪狀病毒單克隆抗體、腺病毒抗體、星狀病毒單克隆抗體、諾如病毒單克隆抗體、幽門螺旋桿菌抗體、隱球菌抗體、腸道病毒抗體、賈第鞭毛蟲抗體、彎曲桿菌抗體、阿米巴原蟲抗體、呼吸道合胞病毒單抗等等。
西班牙Certest腺病毒六鄰體重組蛋白
我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。
歡迎咨詢
歡迎咨詢2042552662
西班牙Certest公司簡介
Certest Biotec, S.L. is an independent biotechnology company devoted to the development and manufacturing of IVD diagnostic products in human clinical field. Our Rapid Test are based in a fast, reliable and easy-interpretation process. In addition, VIASURE contains a wide range of products for Real Time PCR that allow to identify the causal pathogens of the infectious diseases in physicians’ offices, labs and hospitals.
The company was established in Zaragoza in 2002 as an innovative and technology-based company. The company’s growth is based on the development of new products and the exploration for new market niches and opportunities. The key to understand its success is the way to understand its organization: highly specialised and customer-oriented based.
Mission, Vision, Values and Human Team
Mission
To develop, produce and market a wide range of innovative solutions and quality in vitro diagnostics for the detection of viruses, bacteria and parasites.
Vision
Being the international leader company in research and development for in vitro diagnostic solutions, increasing our distribution network through added value creation and company-customer trust.
Values
Customer orientation · Ethical behaviour · Teamwork · Continuous research and innovation ·Trained and motivated team · Quality and creativity in all processes
Human team
The multi-skilled team is a dedicated and experience professional group responsible for dealing with all the different company activities in an international environment.
Commitment to Innovation, Export and High-Technology.
Certest’s Quality System has been certified with ISO 13485.
One of the main objectives of Certest is to achieve customer satisfaction. For this, the management of the company ensures that customer requirements are determined and reviewed, identifying their needs and expectations, and translating them into requirements, all in order to maintain customer satisfaction.
See/Download the Certest Biotec ISO Standard Certification Certest Policy is consistent with its primary purpose, that of getting to all its products and services, quality and reliability, meeting the requirements and maintaining the effectiveness of the management system.
“Comparative study of two diagnostic tests for detection of RNA Zika Virus (ZIKV) in clinical samples”
“Comparison of Real-Time PCR test with the routine diagnosis technique to detect enteric pathogenic protozoa”
“Diagnostic of the Enteric Virus infection by Real-Time PCR in stool samples”
“Clinical performance evaluation of lyophilized VIASURE Real Time PCR Detection Kits for pathogen detection by participation in External Quality Assessment (EQA) programs”
“Detection and differentiation of Influenza A Virus, Influenza B Virus and H1N1 (pdm09) variant through an stabilized Real Time PCR Mix”
“Comparison of different molecular methods for the detection of non-influenza respiratory virus”virus”
【西班牙Certest生物原料】
貨號 | 產品名稱 | 規格 | 英文名稱 |
MT-16R15 | 輪狀病毒單克隆抗體（克隆R15） | x1mg | Anti-Rotavirus Mab (clone R15) |
MT-16R15s1 | 輪狀病毒單克隆抗體（克隆R15） | x100μg | Anti-Rotavirus Mab (clone R15) |
MT-18A15 | 腺病毒抗體（克隆A15） | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-18A15s1 | 腺病毒抗體（克隆A15） | x100μg | Anti-Adenovirus Mab (clone A15) |
MT-18AT18 | 星狀病毒單克隆抗體（克隆AT18） | x1mg | Anti-Astrovirus Mab (clone AT18) |
MT-18AT18s1 | 星狀病毒單克隆抗體（克隆AT18） | x100μg | Anti-Astrovirus Mab (clone AT18) |
MT-18AT8 | 星狀病毒單克隆抗體（克隆AT8） | x1mg | Anti-Astrovirus Mab (clone AT8) |
MT-18AT8s1 | 星狀病毒單克隆抗體（克隆AT8） | x100μg | Anti-Astrovirus Mab (clone AT8) |
MT-18NG28 | 諾如病毒GI單克隆抗體（克隆NG28） | x1mg | Anti-Norovirus GI Mab (clone NG28) |
MT-18NG28sl | 諾如病毒GI單克隆抗體（克隆NG28） | x100μg | Anti-Norovirus GI Mab (clone NG28) |
MT-18NP8 | 諾如病毒GII單克隆抗體（克隆NP8） | x1mg | Anti-Norovirus GII Mab (clone NP8) |
MT-18NP8sl | 諾如病毒GII單克隆抗體（克隆NP8） | x100μg | Anti-Norovirus GII Mab (clone NP8) |
MT-18EV5 | 腸道病毒抗體（克隆EV5） | x1mg | Anti-Enterovirus Mab (clone EV5) |
MT-18EV5sl | 腸道病毒抗體（克隆EV5） | x100μg | Anti-Enterovirus Mab (clone EV5) |
MT-16P2 | 幽門螺旋桿菌抗體（克隆P2）HP抗體 | x1mg | Anti-H. pylori Mab (clone P2) |
MT-16P2sl | 幽門螺旋桿菌抗體（克隆P2）HP抗體 | x100μg | Anti-H. pylori Mab (clone P2) |
MT-16GD10 | 艱難梭菌抗體（克隆GD10） | x1mg | Anti-GDH Mab (clone GD10) |
MT-16GD10sl | 艱難梭菌抗體（克隆GD10） | x100μg | Anti-GDH Mab (clone GD10) |
MT-18TA5 | 艱難梭菌毒素A抗（克隆TA5） | x1mg | Anti-CD Toxin A Mab (clone TA5) |
MT-18TA5sl | 艱難梭菌毒素A抗（克隆TA5） | x100μg | Anti-CD Toxin A Mab (clone TA5) |
MT-18TA7 | 艱難梭菌毒素A抗（克隆TA7） | x1mg | Anti-CD Toxin A Mab (clone TA7) |
MT-18TA7sl | 艱難梭菌毒素A抗（克隆TA7） | x100μg | Anti-CD Toxin A Mab (clone TA7) |
MT-18TB41 | 艱難梭菌毒素B抗（克隆TB41） | x1mg | Anti-CD Toxin B Mab (clone TB41) |
MT-18TB41sl | 艱難梭菌毒素B抗（克隆TB41） | x100μg | Anti-CD Toxin B Mab (clone TB41) |
MT-18TB48 | 艱難梭菌毒素B抗（克隆TB48） | x1mg | Anti-CD Toxin B Mab (clone TB48) |
MT-18TB48sl | 艱難梭菌毒素B抗（克隆TB48） | x100μg | Anti-CD Toxin B Mab (clone TB48) |
MT-18E10 | 大腸桿菌O157抗體（克隆E10） | x1mg | Anti-E. coli O157 Mab (clone E10) |
MT-18E10sl | 大腸桿菌O157抗體（克隆E10） | x100μg | Anti-E. coli O157 Mab (clone E10) |
MT-16CA29 | 彎曲桿菌抗體（克隆ECA29） | x1mg | Anti-Campylobacter Mab (clone CA29) |
MT-16CA29sl | 彎曲桿菌抗體（克隆ECA29） | x100μg | Anti-Campylobacter Mab (clone CA29) |
MT-18K31 | 隱球菌抗體（克隆K31） | x1mg | Anti-Crypto Mab (clone K31) |
MT-18K31sl | 隱球菌抗體（克隆K31） | x100μg | Anti-Crypto Mab (clone K31) |
MT-16G18 | 賈第鞭毛蟲抗體（克隆G18） | x1mg | Anti-Giardia Mab trophozoite protein (clone G18) |
MT-16G18sl | 賈第鞭毛蟲抗體（克隆G18） | x100μg | Anti-Giardia Mab trophozoite protein (clone G18) |
MT-16G22 | 賈第鞭毛蟲抗體（克隆G22） | x1mg | Anti-Giardia Mab trophozoite protein (clone G22) |
MT-16G22sl | 賈第鞭毛蟲抗體（克隆G22） | x100μg | Anti-Giardia Mab trophozoite protein (clone G22) |
MT-18EH30 | 阿米巴原蟲抗體（克隆H30） | x1mg | Anti-Entamoeba Mab (clone EH30) |
MT-18EH30sl | 阿米巴原蟲抗體（克隆H30） | x100μg | Anti-Entamoeba Mab (clone EH30) |
MT-16CP14 | 鈣結合蛋白單克隆抗體（克隆CP14） | x1mg | Anti-Calprotectin Mab (clone CP14) |
MT-16CP14sl | 鈣結合蛋白單克隆抗體（克隆CP14） | x100μg | Anti-Calprotectin Mab (clone CP14) |
MT-16F22 | 血紅蛋白單抗（克隆F22） | x1mg | Anti-Haemoglobin Mab (clone F22) |
MT-16F22sl | 血紅蛋白單抗（克隆F22） | x100μg | Anti-Haemoglobin Mab (clone F22) |
MT-16LC16 | 乳鐵蛋白單抗（克隆LC16） | x1mg | Anti-Lactoferrin Mab (clone LC16) |
MT-16LC16sl | 乳鐵蛋白單抗（克隆LC16） | x100μg | Anti-Lactoferrin Mab (clone LC16) |
MT-16LC4 | 乳鐵蛋白單抗（克隆LC4） | x1mg | Anti-Lactoferrin Mab (clone LC4) |
MT-16LC4sl | 乳鐵蛋白單抗（克隆LC4） | x100μg | Anti-Lactoferrin Mab (clone LC4) |
MT-26VP6 | 輪狀病毒VP6重組蛋白 | x1mg | Rotavirus VP6 recombinant protein |
MT-26VP6 | 輪狀病毒VP6重組蛋白 | x100μg | Rotavirus VP6 recombinant protein |
MT-25HEX | 腺病毒HEXON重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-25HEXsl | 腺病毒HEXON重組蛋白 | x100μg | Adenovirus HEXON recombinant protein |
MT-25AST | 星狀病毒衣殼重組蛋白 | x1mg | Astrovirus capsid recombinant protein |
MT-25ASTsl | 星狀病毒衣殼重組蛋白 | x100μg | Astrovirus capsid recombinant protein |
MT-25NGI1 | 諾如病毒GI.1重組P結構域 | x1mg | Norovirus GI.1 recombinant P domain |
MT-25NGI1sl | 諾如病毒GI.1重組P結構域 | x100μg | Norovirus GI.1 recombinant P domain |
MT-25NGI3 | 諾如病毒GI.3重組P結構域 | x1mg | Norovirus GI.3 recombinant P domain |
MT-25NGI3sl | 諾如病毒GI.3重組P結構域 | x100μg | Norovirus GI.3 recombinant P domain |
MT-25NGII10 | 諾如病毒GII.10重組P結構域 | x1mg | Norovirus GII.10 recombinant P domain |
MT-25NGII10sl | 諾如病毒GII.10重組P結構域 | x100μg | Norovirus GII.10 recombinant P domain |
MT-25NGII17 | 諾如病毒GII.17重組P結構域 | x1mg | Norovirus GII.17 recombinant P domain |
MT-25NGII17sl | 諾如病毒GII.17重組P結構域 | x100μg | Norovirus GII.17 recombinant P domain |
MT-25NGII14 | 諾如病毒GII.4重組P結構域 | x1mg | Norovirus GII.4 recombinant P domain |
MT-25NGII14sl | 諾如病毒GII.4重組P結構域 | x100μg | Norovirus GII.4 recombinant P domain |
MT-25ETV | 腸道病毒VP1重組蛋白 | x1mg | Enterovirus VP1 recombinant protein |
MT-25ETVs1 | 腸道病毒VP1重組蛋白 | x100μg | Enterovirus VP1 recombinant protein |
MT-25PCH | 幽門螺桿菌重組外膜蛋白 | x1mg | H. pylori recombinant outer membrane protein |
MT-25PCHs1 | 幽門螺桿菌重組外膜蛋白 | x100μg | H. pylori recombinant outer membrane protein |
MT-25GDH | 艱難梭菌GDH重組蛋白 | x1mg | Clostridium difficile GDH recombinant protein |
MT-25GDHsl | 艱難梭菌GDH重組蛋白 | x100μg | Clostridium difficile GDH recombinant protein |
MT-24TXA | 艱難梭菌毒素A重組蛋白（無毒性片段） | x1mg | C. difficile Toxin A recombinant protein (fragment without toxic activity) |
MT-24TXAsl | 艱難梭菌毒素A重組蛋白（無毒性片段） | x100μg | C. difficile Toxin A recombinant protein (fragment without toxic activity) |
MT-24TXB | 艱難梭菌毒素B重組蛋白（無毒性片段） | x1mg | C. difficile Toxin B recombinant protein (fragment without toxic activity) |
MT-24TXBsl | 艱難梭菌毒素B重組蛋白（無毒性片段） | x100μg | C. difficile Toxin B recombinant protein (fragment without toxic activity) |
MT-25STX | 大腸桿菌O157 VT1重組蛋白 | x1mg | E. coli O157 VT1 recombinant protein |
MT-25STXsl | 大腸桿菌O157 VT1重組蛋白 | x100μg | E. coli O157 VT1 recombinant protein |
MT-25VT2 | 大腸桿菌O157 VT2重組蛋白 | x1mg | E. coli O157 VT2 recombinant protein |
MT-25VT2sl | 大腸桿菌O157 VT2重組蛋白 | x100μg | E. coli O157 VT2 recombinant protein |
MT-25CCP | 彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter coli recombinant outer membrane protein |
MT-25CCPsl | 彎曲桿菌重組外膜蛋白 | x100μg | Campylobacter coli recombinant outer membrane protein |
MT-25CEP | 空腸彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter jejuni recombinant outer membrane protein |
MT-25CEPsl | 空腸彎曲桿菌重組外膜蛋白 | x100μg | Campylobacter jejuni recombinant outer membrane protein |
MT-25A1G | 賈第蟲腸道滋養體重組蛋白 | x1mg | Giardia intestinalis trophozoite recombinant protein |
MT-25A1Gsl | 賈第蟲腸道滋養體重組蛋白 | x100μg | Giardia intestinalis trophozoite recombinant protein |
MT-25GCP | 賈第蟲腸囊菌重組蛋白 | x1mg | Giardia intestinalis cyst recombinant protein |
MT-25GCPsl | 賈第蟲腸囊菌重組蛋白 | x100μg | Giardia intestinalis cyst recombinant protein |
MT-25EDP | 內阿米巴重組蛋白 | x1mg | Entamoeba dispar recombinant protein |
MT-25EDPsl | 內阿米巴重組蛋白 | x100μg | Entamoeba dispar recombinant protein |
MT-25EHP | 溶組織內阿米巴重組蛋白 | x1mg | Entamoeba histolytica recombinant protein |
MT-25EHPsl | 溶組織內阿米巴重組蛋白 | x100μg | Entamoeba histolytica recombinant protein |
MT-25HCP | 人類鈣衛蛋白重組蛋白 | x1mg | Human Calprotectin recombinant protein |
MT-25HCPs1 | 人類鈣衛蛋白重組蛋白 | x100μg | Human Calprotectin recombinant protein |
MT-31NGA | 諾如病毒GI.1重組VLP | x1mg | Norovirus GI.1 recombinant VLP |
MT-31NGAsl | 諾如病毒GI.1重組VLP | x100μg | Norovirus GI.1 recombinant VLP |
MT-31NPA | 諾如病毒GII.4重組VLP | x1mg | Norovirus GII.4 recombinant VLP |
MT-31NPAsl | 諾如病毒GII.4重組VLP | x100μg | Norovirus GII.4 recombinant VLP |
MT-28PECU | 滅活的幽門螺桿菌抗原（天然提取物） | x1mg | Inactivated H. pylori antigen (native extract) |
MT-28PECUsl | 滅活的幽門螺桿菌抗原（天然提取物） | x100μg | Inactivated H. pylori antigen (native extract) |
MT-28EC7U | 滅活的大腸桿菌O157抗原（天然提取物） | x1mg | Inactivated E. coli O157 antigen (native extract) |
MT-28EC7Usl | 滅活的大腸桿菌O157抗原（天然提取物） | x100μg | Inactivated E. coli O157 antigen (native extract) |
MT-28CCU | 滅活的大腸桿菌抗原（天然提取物） | x1mg | Inactivated Campylobacter coli antigen (native extract) |
MT-28CCUsl | 滅活的大腸桿菌抗原（天然提取物） | x100μg | Inactivated Campylobacter coli antigen (native extract) |
MT-28CJU | 滅活的空腸彎曲桿菌抗原（天然提取物） | x1mg | Inactivated Campylobacter jejuni antigen (native extract) |
MT-28CJUsl | 滅活的空腸彎曲桿菌抗原（天然提取物） | x100μg | Inactivated Campylobacter jejuni antigen (native extract) |
MT-28SEU | 滅活腸炎沙門氏菌抗原（天然提取物） | x1mg | Inactivated Salmonella enteritidis antigen (native extract) |
MT-28SEUs1 | 滅活腸炎沙門氏菌抗原（天然提取物） | x100μg | Inactivated Salmonella enteritidis antigen (native extract) |
MT-28SPAU | 滅活沙門氏菌副傷寒A抗原（天然提取物） | x1mg | Inactivated Salmonella paratyphi A antigen (native extract) |
MT-28SPAUsl | 滅活沙門氏菌副傷寒A抗原（天然提取物） | x100μg | Inactivated Salmonella paratyphi A antigen (native extract) |
MT-28SPBU | 滅活沙門氏菌副傷寒B抗原（天然提取物） | x1mg | Inactivated Salmonella paratyphi B antigen (native extract) |
MT-28SPBUsl | 滅活沙門氏菌副傷寒B抗原（天然提取物） | x100μg | Inactivated Salmonella paratyphi B antigen (native extract) |
MT-28STMU | 滅活的鼠傷寒沙門氏菌抗原（天然提取物） | x1mg | Inactivated Salmonella typhimurium antigen (native extract) |
MT-28STMUsl | 滅活的鼠傷寒沙門氏菌抗原（天然提取物） | x100μg | Inactivated Salmonella typhimurium antigen (native extract) |
MT-28STU | 滅活傷寒沙門氏菌抗原（天然提取物） | x1mg | Inactivated Salmonella typhi antigen (native extract) |
MT-28STUsl | 滅活傷寒沙門氏菌抗原（天然提取物） | x100μg | Inactivated Salmonella typhi antigen (native extract) |
MT-28LMU | 滅活的單核細胞增生李斯特菌抗原（天然提取物） | x1mg | Inactivated Listeria monocytogenes antigen (native extract) |
MT-28LMUsl | 滅活的單核細胞增生李斯特菌抗原（天然提取物） | x100μg | Inactivated Listeria monocytogenes antigen (native extract) |
MT-28YE3U | 滅活小腸結腸炎耶爾森氏菌O:3抗原（天然提取物） | x1mg | Inactivated Yersinia enterocolitica O:3 antigen (native extract) |
MT-28YE3Usl | 滅活小腸結腸炎耶爾森氏菌O:3抗原（天然提取物） | x100μg | Inactivated Yersinia enterocolitica O:3 antigen (native extract) |
MT-28YE9U | 滅活小腸結腸炎耶爾森氏菌O:9抗原（天然提取物） | x1mg | Inactivated Yersinia enterocolitica O:9 antigen (native extract) |
MT-28YE9Usl | 滅活小腸結腸炎耶爾森氏菌O:9抗原（天然提取物） | x100μg | Inactivated Yersinia enterocolitica O:9 antigen (native extract) |
MT-28SBU | 滅活的鮑氏志賀氏菌抗原（天然提取物） | x1mg | Inactivated Shigella boydii antigen (native extract) |
MT-28SBUsl | 滅活的鮑氏志賀氏菌抗原（天然提取物） | x100μg | Inactivated Shigella boydii antigen (native extract) |
MT-28SDU | 滅活的痢疾志賀氏菌抗原（天然提取物） | x1mg | Inactivated Shigella dysenteriae antigen (native extract) |
MT-28SDUsl | 滅活的痢疾志賀氏菌抗原（天然提取物） | x100μg | Inactivated Shigella dysenteriae antigen (native extract) |
MT-28SFU | 滅活的福氏志賀氏菌抗原（天然提取物） | x1mg | Inactivated Shigella flexneri antigen (native extract) |
MT-28SFUdl | 滅活的福氏志賀氏菌抗原（天然提取物） | x100μg | Inactivated Shigella flexneri antigen (native extract) |
MT-28SSU | 滅活的宋內氏志賀菌抗原（天然提取物） | x1mg | Inactivated Shigella sonnei antigen (native extract) |
MT-28SSUsl | 滅活的宋內氏志賀菌抗原（天然提取物） | x100μg | Inactivated Shigella sonnei antigen (native extract) |
MT-29KOE | 滅活小球隱孢子蟲抗原（天然提取物） | x1mg | Inactivated Cryptosporidium parvum antigen (native extract) |
MT-29KOEsl | 滅活小球隱孢子蟲抗原（天然提取物） | x100μg | Inactivated Cryptosporidium parvum antigen (native extract) |
MT-29HHB | 人血紅蛋白蛋白質（天然提取物） | x1mg | Human Haemoglobin protein (native extract) |
MT-29HHBsl | 人血紅蛋白蛋白質（天然提取物） | x100μg | Human Haemoglobin protein (native extract) |
MT-29HLF | 人乳鐵蛋白蛋白質（天然提取物） | x1mg | Human Lactoferrin protein (native extract) |
MT-29HLF | 人乳鐵蛋白蛋白質（天然提取物） | x100μg | Human Lactoferrin protein (native extract) |
MT-29HTF | 人轉鐵蛋白蛋白質（天然提取物） | x1mg | Human Transferrin protein (native extract) |
MT-29HTFsl | 人轉鐵蛋白蛋白質（天然提取物） | x100μg | Human Transferrin protein (native extract) |
MT-20TSS | 溶血性A鏈球菌抗體 | x1mg | Anti-Strep A Pab |
MT-20TSSsl | 溶血性A鏈球菌抗體 | x100μg | Anti-Strep A Pab |
MT-18RV3 | 呼吸道合胞病毒單抗（克隆RV3） | x1mg | Anti-RSV Mab (clone RV3) |
MT-18RV3sl | 呼吸道合胞病毒單抗（克隆RV3） | x100μg | Anti-RSV Mab (clone RV3) |
MT-18RV4 | 呼吸道合胞病毒單抗（克隆RV4） | x1mg | Anti-RSV Mab (clone RV4) |
MT-18RV4sl | 呼吸道合胞病毒單抗（克隆RV4） | x100μg | Anti-RSV Mab (clone RV4) |
MT-18A14 | 腺病毒單克隆抗體（克隆A14） | x1mg | Anti-Adenovirus Mab (clone A14) |
MT-18A14sl | 腺病毒單克隆抗體（克隆A14） | x100μg | Anti-Adenovirus Mab (clone A14) |
MT-18A15 | 腺病毒單克隆抗體（克隆A15） | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-18A15Rsl | 腺病毒單克隆抗體（克隆A15） | x100μg | Anti-Adenovirus Mab (clone A15) |
MT-18Y77 | 甲型流感病毒單抗（克隆Y77） | x1mg | Anti-Influenza A Mab (clone Y77) |
MT-18Y77sl | 甲型流感病毒單抗（克隆Y77） | x100μg | Anti-Influenza A Mab (clone Y77) |
MT-18YB91 | 乙型流感病毒單抗（克隆YB91） | x1mg | Anti-Influenza B Mab (clone YB91) |
MT-18YB91sl | 乙型流感病毒單抗（克隆YB91） | x100μg | Anti-Influenza B Mab (clone YB91) |
MT-18LN14 | 嗜肺軍團菌單抗(克隆LN14) | x1mg | Anti-Legionella pneumophila Mab (clone LN14) |
MT-18LN14sl | 嗜肺軍團菌單抗(克隆LN14) | x100μg | Anti-Legionella pneumophila Mab (clone LN14) |
MT-18LN29 | 嗜肺軍團菌單抗(克隆LN29) | x1mg | Anti-Legionella pneumophila Mab (clone LN29) |
MT-18LN29sl | 嗜肺軍團菌單抗(克隆LN29) | x100μg | Anti-Legionella pneumophila Mab (clone LN29) |
MT-18SN3 | 肺炎鏈球菌單克隆抗體(克隆SN3) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN3) |
MT-18SN3s1 | 肺炎鏈球菌單克隆抗體(克隆SN3) | x100μg | Anti-Streptococcus pneumoniae Mab (clone SN3) |
MT-18SN4 | 肺炎鏈球菌單克隆抗體(克隆SN4) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN4) |
MT-18SN4sl | 肺炎鏈球菌單克隆抗體(克隆SN4) | x100μg | Anti-Streptococcus pneumoniae Mab (clone SN4) |
MT-25RSV | 呼吸道合胞病毒重組融合蛋白 | x1mg | RSV recombinant fusion protein |
MT-25RSVsl | 呼吸道合胞病毒重組融合蛋白 | x100μg | RSV recombinant fusion protein |
MT-25HEXR | 腺病毒六鄰體重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-25HEXRsl | 腺病毒六鄰體重組蛋白 | x100μg | Adenovirus HEXON recombinant protein |
MT-25FAN | 甲型流感病毒重組核蛋白 | x1mg | Influenza A recombinant nucleoprotein |
MT-25FANsl | 甲型流感病毒重組核蛋白 | x100μg | Influenza A recombinant nucleoprotein |
MT-25FBN | 乙型流感病毒重組核蛋白 | x1mg | Influenza B recombinant nucleoprotein |
MT-25FBNsl | 乙型流感病毒重組核蛋白 | x100μg | Influenza B recombinant nucleoprotein |
MT-28SAGU | 滅活A鏈球菌抗原（天然提取物） | x1mg | Inactivated STREP A antigen (native extract) |
MT-28SAGUsl | 滅活A鏈球菌抗原（天然提取物） | x100μg | Inactivated STREP A antigen (native extract) |
MT-29RVV | 滅活呼吸道合胞病毒抗原（天然提取物） | x1mg | Inactivated RSV antigen (native extract) |
MT-29RVVsl | 滅活呼吸道合胞病毒抗原（天然提取物） | x100μg | Inactivated RSV antigen (native extract) |
MT-28LNU | 滅活的嗜肺軍團菌抗原（天然提取物） | x1mg | Inactivated Legionella pneumophila antigen (native extract) |
MT-28LNUsl | 滅活的嗜肺軍團菌抗原（天然提取物） | x100μg | Inactivated Legionella pneumophila antigen (native extract) |
MT-28SPNU | 滅活的肺炎鏈球菌抗原（天然提取物） | x1mg | Inactivated Streptococcus pneumoniae antigen (native extract) |
MT-28SPNUsl | 滅活的肺炎鏈球菌抗原（天然提取物） | x100μg | Inactivated Streptococcus pneumoniae antigen (native extract) |
西班牙Certest腺病毒六鄰體重組蛋白
提高測序覆蓋率在一定程度上可以有效減少基因組中的Gap，但成本相對較高，并且對于一些復雜的微生物基因組效果有限，如454二代測序覆蓋率為10×時，喜溫硫桿菌SM-1測序后生成的Gap數目為400個；測序覆蓋率提高至25×時，Gap數目減少至280個；但當測序覆蓋率繼續提高至38×時，Gap數目進入平臺期(276個)，相比25×測序覆蓋率時僅減少了4個，已經不能再單純通過提高覆蓋率來減少Gap數目。因此，對于復雜的微生物基因組，需要將基因組的Gap closure分為幾個階段，針對不同階段采用相應的策略進行：如果Gap數目大于200個，可以通過構建基因組文庫、Paired-End測序或者采用基因組光學圖譜技術的策略確定Contig之間的相對位置和順序，然后再依次關閉Contig之間的Gap區域；當Ga數目小于100個時，可以采用多引物PCR的策略尋找Linkage信息，關閉所有能夠關閉的Gap；如果zui后還剩余幾個Gap無法關閉，則可以采用基因組步移或文庫篩選的策略，如在對喜溫硫桿菌SM-1基因組Gap closure時，通過結合構建基因組文庫、Paired-End測序、多引物PCR以及Fosimid文庫篩選等多種策略zui終完成了SM-1基因組的Gap closure。
由于新一代測序技術測序讀長較短、基因組結構的復雜性以及測序過程中的偏向性等原因，使得已完成測序的一些物種的基因組中含有數目不等的空缺區域。據統計，自2008年以來，GenBank釋放的5276個微生物基因組序列中僅有32% (1692)是完整序列?；蚪M空缺區域中可能存在重要的生物學信息，如果不能補齊所有的Gap，不僅無法獲得完整的基因組圖譜，還會給后續的基因組信息解讀(操縱子結構、基因調控、SNP分析以及比較基因組等)造成困難。因此，完整微生物基因組序列的獲得需要在完成測序之后對空缺區域進行填充，即將測序拼裝后生成的疊聯群(Contig)之間的Gap進行填充，然后按照一定的次序和方向拼裝生成一條完整的基因組序列(完成圖)，這個過程稱之為基因組的Gap closure (或補洞)。
基因組光學圖譜技術是一種利用單分子DNA的限制性內切酶圖譜生成高分辨率、有序的全基因組限制性內切酶酶切圖譜的方法。
2010年，OpGen公司推出了基于光學圖譜技術的自動化的基因組拼接和數據分析系統——Argus?工作站，能夠在一個工作日內獲得待測微生物基因組的高質量全基因組限制性內切酶酶切圖譜。該系統主要由Mapcard加工工作站、光學掃描系統和數據處理工作站等組成，通過限制性內切酶對固定于MapCard DNA surface區域中的單分子DNA進行原位切割，使切割后的DNA片段順序保持不變。DNA片段經熒光染料染色后置于熒光顯微鏡下，采集每個限制性內切酶片段的大小和順序的信息，信息經轉換處理后生成單個DNA分子的限制性內切酶酶切位點圖譜，zui后根據全部DNA分子限制性內切酶酶切位點圖譜的相互重疊部分拼接得到全基因組限制性內切酶酶切位點圖譜。該系統zui初被應用于微生物基因組序列組裝、比較基因組學以及菌株分類，目前已經開始在人類和動植物全基因組組裝中應用。
西班牙
我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、食品安全、化妝品檢測、藥物濫用檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。
想了解更多的產品及服務請掃描下方二維碼：
【公司名稱】 廣州健侖生物科技有限公司
【市場部】 楊永漢
【】
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室
Increasing sequencing coverage can effectively reduce Gap in the genome to a certain extent, but the cost is relatively high, and the effect is limited for some complicated microbial genomes. For example, when the 454 second-generation sequencing coverage is 10 ×, 1, the number of Gap generated after sequencing was 400. When the coverage increased to 25 ×, the number of Gap decreased to 280. However, when the coverage of sequencing continued to increase to 38 ×, the number of Gap entered platform (276) Only a 4-fold decrease compared to 25 × sequencing coverage. It is no longer possible to reduce the number of Gaps simply by increasing the coverage. Therefore, for complex microbial genomes, it is necessary to divide the genomic Gap closure into several stages and adopt corresponding strategies for different stages. If the Gap number is more than 200, the Gap closure may be performed by constructing a genomic library, Paired-End sequencing, or using genomic optics The strategy of the map technology determines the relative position and order of the Contigs, and then turns off the Gap regions between the Contigs in sequence. When the number of Ga is less than 100, the strategy of the multi-primer PCR can be used to find the Linkage information and close all the Gaps ; If the last remaining few Gap can not be shut down, you can use the strategy of genome walking or library screening, such as in the Gap closure of the SM-1 genome of Thermus thermophilus by combining the construction of the genomic library, Paired-End sequencing, and more Primer PCR and Fosimid library screening strategies such as the final completion of the SM-1 genome Gap closure.
Due to the short sequencing length of new-generation sequencing technologies, the complexity of the genome structure and the bias in the sequencing process, some of the previously sequenced genomes contain a variable number of vacant genomes. According to statistics, only 32% (1692) of 5276 microbial genome sequences released by GenBank since 2008 are the complete sequences. There may be important biological information in the genomic locus where not all of the Gap can be populated, not only failing to obtain a complete genome map, but also interpreting subsequent genomic information (operon structure, gene regulation, SNP analysis, and comparative genomics Cause difficulties. Therefore, the complete microbial genome sequence needs to be filled after the completion of the sequencing of the vacancy region, that is to say, the Gap between contigs generated after sequencing and assembly is filled in, and then assembled according to a certain order and direction to generate a complete Genome sequence (complete map), this process is called the genome Gap closure (or fill hole).
Genome-wide optical mapping is a method of generating high-resolution, ordered whole-genome restriction digest maps using restriction endonuclease mapping of single-molecule DNA.
In 2010, OpGen introduced the Argus ™ workstation, an automated genome splicing and data analysis system based on patented optical mapping technology, that cleans high-quality whole-genome restriction endonucleases of the microbe genome under test within one business day Map. The system mainly consists of a Mapcard processing workstation, an optical scanning system, a data processing workstation and the like. The single-molecule DNA immobilized on the MapCard DNA surface is cut in situ by a restriction enzyme to keep the cut DNA fragments in sequence change. The DNA fragment was stained with fluorescent dye and then placed under a fluorescence microscope to collect the size and sequence information of each restriction enzyme fragment. The information was transformed and processed to generate the restriction enzyme site map of a single DNA molecule, Finally, a complete genome restriction endonuclease map was obtained by splicing the overlapping parts of all the DNA restriction endonuclease sites. The system was initially applied to the assembly of microbial genome sequences, comparative genomics and strain classification and has now been applied to the whole genome assembly of humans and animals and plants.
